Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 1996
Grade5.8
◀ Past 5.9● Present 6.3▶ Future 4.9
Who runs Teva Pharmaceutical Industries Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Francis Richard D
President and CEO. First filing Jan 2023, latest Nov 12, 2026, 11 filings in all.
Officers reporting now
13
of 23 people with a filing in the last fifteen months
Directors reporting now
10
48 people on the record since 2018
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Francis Richard D | President and CEO | Jan 2023 | Nov 12, 2026 | 8 · $41.8M |
| Bergwerk Dov | Interim Chief Legal Officer | Oct 2023 | Nov 12, 2026 | 2 · $1.1M |
| Weiss Amir | Chief Accounting Officer | Dec 2021 | Nov 12, 2026 | 7 · $1.9M |
| Daniell Richard | EVP, Europe Commercial | Jan 2018 | Nov 12, 2026 | 10 · $14.0M |
| Sabag Mark | See "Remarks" | Feb 2018 | Nov 12, 2026 | 6 · $17.0M |
| Savage Brian | Interim Chief Legal Officer | Feb 2026 | Sep 22, 2026 | 7 · $400,000 |
| Lippman Evan | EVP, Business Development | Apr 2025 | Aug 19, 2026 | 3 · $2.2M |
| Hughes Eric A | "See ""Remarks""" | Aug 2022 | Aug 5, 2026 | 5 · $4.2M |
| Jover Placid | "See ""Remarks""" | Aug 2024 | Aug 5, 2026 | 2 · $900,000 |
| Shields Matthew | EVP, Global Operations | Jun 2024 | Jun 22, 2026 | 3 · $1.4M |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Jan 2020 | Jun 16, 2026 | 3 · $20.7M |
| Fox Christine | EVP, U.S. Commercial | Nov 2023 | May 4, 2026 | 5 · $2.7M |
| Mcavoy David R. | EVP, Chief Legal Officer | Mar 2024 | Sep 9, 2025 | none |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Brailer David J | director | Nov 2026 | Nov 12, 2026 | none |
| Mignone Roberto | director | Jan 2018 | Sep 22, 2026 | 3 · $18.0M |
| Satchi-Fainaro Ronit | director | Jun 2018 | Aug 25, 2026 | 1 · $0.00 |
| Zaks Tal Zvi | director | Oct 2021 | Aug 10, 2026 | 1 · $0.00 |
| Barer Sol J | director | Jan 2018 | Jun 8, 2026 | none |
| Crane Rosemary A | director | Jan 2018 | Jun 8, 2026 | none |
| Elstein Amir | director | Jan 2018 | Jun 8, 2026 | none |
| Lichtenstein Chen | director | Dec 2024 | Jun 8, 2026 | none |
| Lieberman Gerald M | director | Jan 2018 | Jun 8, 2026 | none |
| Nisen Perry | director | Jan 2018 | Jun 8, 2026 | none |
Earlier names on the record25, newest filing first
Shalev Varda · director · last filing Jun 2025Vergis Janet S. · director · last filing Jun 2025Grant Angus · officer · last filing Aug 2024Conway Vikki L · officer · last filing May 2024Drape Eric · officer · last filing Mar 2024Stark David Matthew · officer · last filing Mar 2023Dethlefs Sven · officer · last filing Mar 2023Inbar Galia · officer · last filing Mar 2023Shani Eli · officer · last filing Mar 2023Schultz Kare · officer · last filing Nov 2022Halfon Jean Michel · director · last filing Aug 2022Peres Nechemia Jacob · director · last filing Aug 2022Fridriksdottir Hafrun · officer · last filing May 2022Weil Andrew · officer · last filing Nov 2021Hussain Abbas · director · last filing Jun 2021Nazzi Gianfranco · officer · last filing Mar 2021O'Grady Brendan P. · officer · last filing Mar 2021Griffin Deborah A · officer · last filing Mar 2020Mcclellan Michael James · officer · last filing Nov 2019Goldberg Murray A · director · last filing Jun 2019De Notaristefani Carlo · officer · last filing May 2019Codner Iris Beck · officer · last filing Mar 2019Suesskind Dan S · director · last filing Feb 2018Greene-Sulzberger Gabrielle · director · last filing Jan 2018Maor Galia · director · last filing Jan 2018
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.